Pain management in cattle has historically been neglected relative to companion animals. Cultural attitudes, cost considerations, limited product availability, and the need for veterinary prescription have all contributed to underuse of analgesia in cattle farming. This is changing as welfare science advances and regulatory requirements strengthen.
The Case for Pain Management
Cattle experience pain from a wide range of conditions: lameness, mastitis, calving difficulties, dehorning, castration, and surgical procedures. Pain causes suffering, reduces feed intake and productivity, impairs immune function, and slows recovery. Effective pain management improves welfare outcomes and can be economically beneficial through faster recovery and improved production.
Available Analgesics
NSAIDs (non-steroidal anti-inflammatory drugs): Meloxicam and flunixin are licensed for cattle in the UK. Meloxicam is longer-acting (24h) and preferred for post-operative and chronic pain. Flunixin is effective for acute pain (endotoxaemia, colic). Ketoprofen and carprofen are also available. All require veterinary prescription.
Local anaesthesia: Lidocaine is used for surgical procedures (nerve blocks, epidurals, local infiltration). Essential for dehorning, disbudding, caesarean, and digit amputation. Prolonged procedures require adequate volume and time for onset.
Opioids: Limited availability and use in cattle; butorphanol is occasionally used for severe pain but withdrawal periods and regulatory constraints limit application.
Key Applications
Current evidence strongly supports analgesia in:
Disbudding/dehorning: NSAID + local anaesthesia is now considered minimum standard; sedation improves welfare further. Inadequate pain control for disbudding is a welfare offence in many contexts.
Castration: Local anaesthesia reduces acute pain; NSAID provides post-operative analgesia
Mastitis: NSAID administration alongside antibiotic treatment improves welfare and may reduce somatic cell count
Barriers to Uptake
Despite strong evidence, analgesia use in cattle remains lower than optimal: cost (though often small relative to value of the animal); veterinary prescription requirement creating access barriers; long withdrawal periods for some products; and attitudinal barriers among some producers. Education, proactive prescription by herd vets, and inclusion in herd health plans all increase uptake.